233 related articles for article (PubMed ID: 25817052)
1. Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review.
Luk F; de Witte SF; Bramer WM; Baan CC; Hoogduijn MJ
Expert Rev Clin Immunol; 2015 May; 11(5):617-36. PubMed ID: 25817052
[TBL] [Abstract][Full Text] [Related]
2. Are mesenchymal stromal cells immune cells?
Hoogduijn MJ
Arthritis Res Ther; 2015 Mar; 17(1):88. PubMed ID: 25880839
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: A systematic review.
Hynes K; Bright R; Proudman S; Haynes D; Gronthos S; Bartold M
Semin Arthritis Rheum; 2016 Aug; 46(1):1-19. PubMed ID: 27105756
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo?
Consentius C; Reinke P; Volk HD
Regen Med; 2015; 10(3):305-15. PubMed ID: 25933239
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation.
Casiraghi F; Noris M; Remuzzi G
Curr Opin Organ Transplant; 2010 Dec; 15(6):731-7. PubMed ID: 20881495
[TBL] [Abstract][Full Text] [Related]
6. Could mesenchymal stromal cells have a role in childhood autoimmune diseases?
Pesmatzoglou M; Dimitriou H; Stiakaki E
Immunol Invest; 2013; 42(7):639-56. PubMed ID: 24004061
[TBL] [Abstract][Full Text] [Related]
7. [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?].
Larghero J; Vija L; Lecourt S; Michel L; Verrecchia F; Farge D
Rev Med Interne; 2009 Mar; 30(3):287-99. PubMed ID: 18930338
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials.
Wang LT; Ting CH; Yen ML; Liu KJ; Sytwu HK; Wu KK; Yen BL
J Biomed Sci; 2016 Nov; 23(1):76. PubMed ID: 27809910
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells for treating autoimmune dacryoadenitis.
Lu X; Wang X; Nian H; Yang D; Wei R
Stem Cell Res Ther; 2017 Jun; 8(1):126. PubMed ID: 28583168
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell treatment for autoimmune diseases: a critical review.
Figueroa FE; Carrión F; Villanueva S; Khoury M
Biol Res; 2012; 45(3):269-77. PubMed ID: 23283436
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
[TBL] [Abstract][Full Text] [Related]
12. The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy.
Hoogduijn MJ; Popp F; Verbeek R; Masoodi M; Nicolaou A; Baan C; Dahlke MH
Int Immunopharmacol; 2010 Dec; 10(12):1496-500. PubMed ID: 20619384
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effect of tonsil-derived mesenchymal stem cells in a mouse model of allergic rhinitis.
Samivel R; Kim EH; Chung YJ; Mo JH
Am J Rhinol Allergy; 2015; 29(4):262-7. PubMed ID: 26085003
[TBL] [Abstract][Full Text] [Related]
14. [Mesenchymal stem/stroma cells : Therapeutic potential in the treatment of autoimmune diseases].
Schäfer R; Daikeler T
Z Rheumatol; 2016 Oct; 75(8):786-794. PubMed ID: 27481118
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
16. [Application of mesenchymal stem cell in immunotherapy--review].
Liao LM; Han Q; Zhao CH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):158-63. PubMed ID: 15748459
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stromal Cell Therapy in MDR/XDR Tuberculosis: A Concise Review.
Joshi L; Chelluri LK; Gaddam S
Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):427-33. PubMed ID: 26100384
[TBL] [Abstract][Full Text] [Related]
18. The potential of mesenchymal stromal cells in immunotherapy.
Fayyad-Kazan M; Fayyad-Kazan H; Lagneaux L; Najar M
Immunotherapy; 2016 Jul; 8(8):839-42. PubMed ID: 27381681
[No Abstract] [Full Text] [Related]
19. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 Indicates Therapeutic Efficacy of Mesenchymal Stem Cells in Experimental Traumatic Brain Injury.
Kota DJ; Prabhakara KS; Toledano-Furman N; Bhattarai D; Chen Q; DiCarlo B; Smith P; Triolo F; Wenzel PL; Cox CS; Olson SD
Stem Cells; 2017 May; 35(5):1416-1430. PubMed ID: 28233425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
